During the past decade, Alamo Clinical Research Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 12 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alamo Clinical Research Associates" #1 sponsor was "Gilead Sciences" with 6 trials, followed by "Eisai Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Pharmaxis" with 2 trials sponsored and "Parion Sciences" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alamo Clinical Research Associates" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Argentina: Resolution Latin America; Buenos Aires, Argentina" with 1 trials as a collaborator, "Europe: KasaConsult bvba, Hoegaarden, Belgium" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Vertex Pharmaceuticals Incorporated" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Alamo Clinical Research Associates" are "Cystic Fibrosis" (5 trials), "Bronchiectasis" (2 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (2 trials), "Down Syndrome" (2 trials) and "Liver Fibrosis Due to NASH" (2 trials). Many other conditions were trialed in "Alamo Clinical Research Associates" in a lesser frequency.

Most popular intervention types in "Alamo Clinical Research Associates" are "Drug" (14 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AZLI" (2 trials), "SIM" (2 trials), "6-minutes walk performance" (1 trials) and "AZLI 75 mg three times a day (TID)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alamo Clinical Research Associates" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Alamo Clinical Research Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Alamo Clinical Research Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Alamo Clinical Research Associates, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".